AU Stock MarketDetailed Quotes

OSLOB OncoSil Medical Ltd

Watchlist

0.002
0.0000.00%

20min DelayMarket Closed Nov 15 10:06 AET

8.97MMarket Cap0.00P/E (Static)

OncoSil Medical Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Total revenue

40.51%516.63K

58.63%367.68K

8.79%231.79K

213.07K

Operating revenue

40.51%516.63K

58.63%367.68K

8.79%231.79K

--213.07K

----

Cost of revenue

-4.97%1.51M

63.37%1.59M

1.19%972.47K

961.02K

Gross profit

18.67%-993.12K

-64.86%-1.22M

0.97%-740.69K

-747.95K

Operating expense

5.00%12.08M

6.60%11.51M

-2.43%10.8M

50.35%11.06M

7.36M

Selling and administrative expenses

-0.87%6.63M

-6.71%6.69M

7.80%7.17M

291.08%6.65M

--1.7M

-Selling and marketing expense

50.43%196.18K

-64.77%130.42K

-45.94%370.21K

--684.77K

----

-General and administrative expense

-1.89%6.43M

-3.55%6.56M

13.96%6.8M

250.82%5.97M

--1.7M

Research and development costs

4.86%2.99M

19.97%2.85M

-17.70%2.38M

-22.50%2.89M

--3.73M

Depreciation amortization depletion

-74.99%44K

38.60%175.89K

-31.32%126.91K

23.77%184.78K

--149.29K

-Depreciation and amortization

-74.99%44K

38.60%175.89K

-31.32%126.91K

23.77%184.78K

--149.29K

Other operating expenses

34.99%2.42M

59.77%1.79M

-16.26%1.12M

-24.83%1.34M

--1.78M

Operating profit

-2.73%-13.08M

-10.34%-12.73M

2.33%-11.54M

-60.51%-11.81M

-7.36M

Net non-operating interest income (expenses)

21.11%62.62K

644.69%51.71K

-114.22%-9.49K

-28.85%66.74K

93.8K

Non-operating interest income

6.32%66.57K

517.97%62.61K

-87.72%10.13K

-21.36%82.48K

--104.88K

Non-operating interest expense

11,160.00%563

--5

----

25.55%1.08K

--861

Total other finance cost

-68.97%3.38K

-44.48%10.9K

33.81%19.62K

43.45%14.67K

--10.22K

Other net income (expenses)

-8.82%1.06M

67.44%1.16M

-38.58%692.11K

-60.51%1.13M

2.85M

Other non-operating income (expenses)

-8.82%1.06M

67.44%1.16M

-38.58%692.11K

-60.51%1.13M

--2.85M

Income before tax

-5.03%-11.91M

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

-4.26M

Income tax

Earnings from equity interest net of tax

Net income

-5.03%-11.91M

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

-4.26M

Net income continuous operations

-5.03%-11.91M

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

---4.26M

Noncontrolling interests

Net income attributable to the company

-5.03%-11.91M

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

-4.26M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-5.03%-11.91M

-5.74%-11.34M

-2.81%-10.73M

-144.81%-10.43M

-4.26M

Diluted earnings per share

Basic earnings per share

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Total revenue	40.51%516.63K	58.63%367.68K	8.79%231.79K	213.07K
Operating revenue	40.51%516.63K	58.63%367.68K	8.79%231.79K	--213.07K	----
Cost of revenue	-4.97%1.51M	63.37%1.59M	1.19%972.47K	961.02K
Gross profit	18.67%-993.12K	-64.86%-1.22M	0.97%-740.69K	-747.95K
Operating expense	5.00%12.08M	6.60%11.51M	-2.43%10.8M	50.35%11.06M	7.36M
Selling and administrative expenses	-0.87%6.63M	-6.71%6.69M	7.80%7.17M	291.08%6.65M	--1.7M
-Selling and marketing expense	50.43%196.18K	-64.77%130.42K	-45.94%370.21K	--684.77K	----
-General and administrative expense	-1.89%6.43M	-3.55%6.56M	13.96%6.8M	250.82%5.97M	--1.7M
Research and development costs	4.86%2.99M	19.97%2.85M	-17.70%2.38M	-22.50%2.89M	--3.73M
Depreciation amortization depletion	-74.99%44K	38.60%175.89K	-31.32%126.91K	23.77%184.78K	--149.29K
-Depreciation and amortization	-74.99%44K	38.60%175.89K	-31.32%126.91K	23.77%184.78K	--149.29K
Other operating expenses	34.99%2.42M	59.77%1.79M	-16.26%1.12M	-24.83%1.34M	--1.78M
Operating profit	-2.73%-13.08M	-10.34%-12.73M	2.33%-11.54M	-60.51%-11.81M	-7.36M
Net non-operating interest income (expenses)	21.11%62.62K	644.69%51.71K	-114.22%-9.49K	-28.85%66.74K	93.8K
Non-operating interest income	6.32%66.57K	517.97%62.61K	-87.72%10.13K	-21.36%82.48K	--104.88K
Non-operating interest expense	11,160.00%563	--5	----	25.55%1.08K	--861
Total other finance cost	-68.97%3.38K	-44.48%10.9K	33.81%19.62K	43.45%14.67K	--10.22K
Other net income (expenses)	-8.82%1.06M	67.44%1.16M	-38.58%692.11K	-60.51%1.13M	2.85M
Other non-operating income (expenses)	-8.82%1.06M	67.44%1.16M	-38.58%692.11K	-60.51%1.13M	--2.85M
Income before tax	-5.03%-11.91M	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	-4.26M
Income tax	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-5.03%-11.91M	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	-4.26M
Net income continuous operations	-5.03%-11.91M	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	---4.26M
Noncontrolling interests
Net income attributable to the company	-5.03%-11.91M	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	-4.26M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-5.03%-11.91M	-5.74%-11.34M	-2.81%-10.73M	-144.81%-10.43M	-4.26M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data